Status:
COMPLETED
Corneal Collagen Cross-Linking for Ectasia (CXL)
Lead Sponsor:
Glaukos Corporation
Conditions:
Ectasia
Eligibility:
All Genders
14+ years
Phase:
PHASE3
Brief Summary
Prospective, randomized multicenter study to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes with ectasia after refract...
Detailed Description
Subjects are randomized to a control group or a treatment group, with the control group crossed over to the treatment group at the 3 month visit. Corneal collagen cross-linking is performed as a singl...
Eligibility Criteria
Inclusion
- Diagnosis of ectasia after refractive surgery
- Documented ectasia on Pentacam or topography map
- BSCVA worse than 20/20
- Must complete all study visits
Exclusion
- History of delayed wound healing
- History of corneal melt or corneal dystrophy
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00674661
Start Date
December 1 2007
End Date
November 1 2011
Last Update
April 26 2021
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Shiley Eye Center
La Jolla, California, United States, 92093
2
Gordon -Weiss Vision Institute
San Diego, California, United States, 91222
3
Center for Excellence in Eye Care
Miami, Florida, United States, 33176
4
Price Vision Group
Indianapolis, Indiana, United States, 46260